Bloomberg: Arthur Hayes has recently made a significant investment in a human longevity extension company and has been receiving regular intravenous stem cell infusion therapy over the past year.
BlockBeats News, August 21st. According to Bloomberg, BitMEX co-founder Arthur Hayes is shifting his investment focus to the field of human life extension. He recently made a significant investment in a stem cell company with clinics in Mexico and Bangkok, and has joined its board of directors. Over the past year, he has regularly flown to receive intravenous infusion treatments, stating that he "hopes to extend his life as healthily as possible." While the company's name was not disclosed due to ongoing rebranding, he emphasized: "This is a future trend - an increasing number of countries are relaxing regulations on stem cell usage."
Também poderá gostar de
Em alta
Últimas notícias cripto
WSJ: Os investidores estão alertas de uma nova rodada do "Inverno Crypto"
Aethir lança um roteiro futuro de 12 meses para acelerar o crescimento no negócio de computação de IA empresarial global
Lista de entrada/saída de financiamento spot de 24 horas: ETH Net Outflow de US$ 126 milhões, ZEC Net Outflow de US$ 18,2 milhões
Bloomberg: Fed nunca tão dividido sobre a estratégia de taxas longas
Dados de transação chave: Rendimento do Tesouro dos EUA de 10 anos sobe para 4,086%
Apoio ao cliente:@weikecs
Cooperação empresarial:@weikecs
Trading quant. e criação de mercados:[email protected]
Serviços VIP:[email protected]